| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1210/ER.2002-0028 |
| P8608 | Fatcat ID | release_hbkvqqye2vdxjl5hhts6d2meda |
| P953 | full work available at URL | http://academic.oup.com/edrv/article-pdf/24/5/571/8860806/edrv0571.pdf |
| https://academic.oup.com/edrv/article-pdf/24/5/571/8860806/edrv0571.pdf | ||
| P698 | PubMed publication ID | 14570743 |
| P5875 | ResearchGate publication ID | 231586002 |
| P50 | author | B Mark Evers | Q89810329 |
| Mark R. Hellmich | Q109914019 | ||
| Courtney M. Townsend | Q109914034 | ||
| P2093 | author name string | Robert P. Thomas | |
| P2860 | cites work | Involvement of protein kinase C and Src family tyrosine kinase in Galphaq/11-induced activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase | Q77171904 |
| Epidermal growth factor and neurotensin induce microvillus hypertrophy following massive enterectomy | Q77620993 | ||
| Glucagon-like peptide 2 is a potent growth factor for small intestine and colon | Q77621032 | ||
| Somatostatin and the gastrointestinal tract | Q77730744 | ||
| sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1 | Q77754899 | ||
| Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients | Q77926680 | ||
| Characterization of gastrin-releasing peptide receptors aberrantly expressed by non-antral gastric adenocarcinomas | Q78048878 | ||
| The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo | Q78206758 | ||
| Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine | Q80316383 | ||
| A new look at an old hormone gastrin | Q81067661 | ||
| Enhancement of small intestine function by gastrin | Q93579701 | ||
| Parietal Cell Hyperplasia Induced by the Administration of Pentagastrin (ICI 50,123) to Rats | Q113440948 | ||
| Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth | Q22254675 | ||
| Molecular cloning and characterization of receptors for the mammalian bombesin-like peptides | Q24316129 | ||
| The chemical mechanism of gastric secretion | Q24544512 | ||
| Cancer statistics, 2002 | Q28216788 | ||
| Cloning and structural determination of human peptide YY cDNA and gene | Q28259945 | ||
| Transcriptional regulation by MAP kinases | Q28276533 | ||
| Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor | Q28286729 | ||
| Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma | Q28345115 | ||
| G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo | Q28512542 | ||
| Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway | Q30193170 | ||
| G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation | Q31809911 | ||
| SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells | Q31942539 | ||
| Cholecystokinin octapeptide induces both proliferation and apoptosis in the rat pancreas | Q31943795 | ||
| Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells | Q31963627 | ||
| Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. | Q32046736 | ||
| Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. | Q32085854 | ||
| A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. | Q33652314 | ||
| The p38 signal transduction pathway: activation and function | Q33838955 | ||
| Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase | Q33844684 | ||
| Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation | Q33849182 | ||
| Molecular mechanisms for the growth factor action of gastrin. | Q33898149 | ||
| Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras AND Rho-independent pathway | Q33899529 | ||
| Pancreatic cancer: a review of emerging therapies | Q33942341 | ||
| Gastrin does not stimulate growth of the rat pancreas | Q71309909 | ||
| Relationship of gastrin processing to colon cancer | Q71737285 | ||
| Role of bombesin on gut mucosal growth | Q71907217 | ||
| Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors | Q72030775 | ||
| Effects of peptide YY on the growth of the pancreas and intestine | Q72067310 | ||
| Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin | Q72229369 | ||
| Bombesin stimulates mucosal growth in jejunal and ileal Thiry-Vella fistulas | Q72231504 | ||
| Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer | Q72400503 | ||
| Trophic Effects of Gastrin on Colorectal Neoplasms in the Rat | Q72656007 | ||
| Trophic effects of neurotensin in massive bowel resection in the rat | Q72709044 | ||
| Bombesin improves survival from methotrexate-induced enterocolitis | Q72765644 | ||
| Effects of octapeptide-cholecystokinin, secretin, and glucagon on intestinal mucosal growth in parenterally nourished rats | Q72898145 | ||
| Transport of cholecystokinin-octapeptide-like immunoreactivity toward the gut in afferent vagal fibres in cat and dog | Q72915526 | ||
| Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters | Q72969104 | ||
| Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692 | Q73292423 | ||
| Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer | Q73302282 | ||
| Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR | Q73695495 | ||
| Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC) | Q73701862 | ||
| Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis | Q73804509 | ||
| One-year treatment with cholecystokinin-octapeptide and secretin: effects on pancreatic trophism in the rat | Q73878719 | ||
| Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen | Q73977798 | ||
| Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats | Q74049489 | ||
| Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide | Q74239989 | ||
| Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat | Q74385102 | ||
| Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth | Q74515907 | ||
| Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines | Q74586006 | ||
| Regulation of protein synthesis by cholecystokinin in rat pancreatic acini involves PHAS-I and the p70 S6 kinase pathway | Q77164943 | ||
| Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | Q42374570 | ||
| p70s6k is activated by CCK in rat pancreatic acini | Q42442521 | ||
| Dose-related involvement of CCK in bombesin-induced pancreatic growth | Q42454342 | ||
| Duodenogastric reflux enhances growth and carcinogenesis in the rat pancreas | Q42455388 | ||
| The use of a rat isolated ileal preparation to investigate the release of neurotensin | Q42458962 | ||
| Release of ileal neurotensin in the rat by neurotransmitters and neuropeptides | Q42464418 | ||
| Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. | Q42508870 | ||
| Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. | Q43183791 | ||
| Exocrine pancreatic nodules after longterm pancreaticobiliary diversion in rats. An effect of raised CCK plasma concentrations | Q43184058 | ||
| Gastrin and the growth of the gastrointestinal tract | Q43225394 | ||
| Negative control by Sandostatin on pancreatic and duodenal growth: a possible implication of insulin-like growth factor I | Q43569237 | ||
| Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. | Q43576645 | ||
| Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells | Q43594371 | ||
| Dose-dependent induction of glandular stomach preneoplastic and neoplastic lesions in male F344 rats treated with catechol chronically | Q43649838 | ||
| CCK-B/gastrin receptors in human colorectal cancer | Q43758707 | ||
| Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice | Q43849588 | ||
| The incidence and epidemiologic characteristics of neuroblastoma in the United States | Q43993462 | ||
| Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat | Q44090836 | ||
| The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. | Q44952263 | ||
| Is peptide YY trophic to the intestinal epithelium of parenterally fed rats? | Q45064142 | ||
| Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels | Q46112020 | ||
| Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection | Q46216093 | ||
| Gastrin and colorectal cancer: a prospective study | Q46310500 | ||
| Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas | Q46541960 | ||
| Interaction of caerulein and secretin on pancreatic size and composition in rat | Q47313896 | ||
| Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma | Q47894197 | ||
| Isolation, characterization, and developmental expression of the rat peptide-YY gene | Q48233928 | ||
| Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin | Q48286984 | ||
| Cholecystokinin in feline vagal and sciatic nerves: Concentration, molecular form and transport velocity | Q48737401 | ||
| Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. | Q50760925 | ||
| Cancer statistics, 1997. | Q50980276 | ||
| Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. | Q51034919 | ||
| Gastrin levels in patients with colorectal cancer. | Q51574559 | ||
| Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study. | Q51584706 | ||
| Level of serum gastrin as a predictor of liver metastasis from colorectal cancer. | Q51600768 | ||
| Postprandial levels of prolactin and gut hormones in breast cancer patients: association with stage of disease, but not dietary fat. | Q51617132 | ||
| Regulation of antral gastrin content. | Q51644933 | ||
| The neuropeptide bombesin improves IgA-mediated mucosal immunity with preservation of gut interleukin-4 in total parenteral nutrition-fed mice. | Q51729449 | ||
| Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. | Q52134258 | ||
| Fetal and neoplastic expression of the neurotensin gene in the human colon. | Q52201875 | ||
| Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early postnatal period. | Q52242642 | ||
| Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. | Q52828506 | ||
| A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer | Q53027312 | ||
| Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. | Q53397820 | ||
| Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. | Q53412538 | ||
| Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. | Q53497377 | ||
| Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. | Q53512872 | ||
| Cholecystokinin inhibits pancreatic and hepatic carcinogenesis. | Q53562019 | ||
| Role of octreotide in the treatment of pancreatic cancer. | Q53670327 | ||
| Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA). | Q53715465 | ||
| The effects of long-term feeding of soya flour on the rat pancreas | Q70654885 | ||
| High potency of bombesin for stimulation of human gastrin release and gastric acid secretion | Q70842039 | ||
| Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth | Q70880725 | ||
| A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo Clinic | Q71067424 | ||
| Preservation of intestine protein by peptide YY during total parenteral nutrition | Q71094590 | ||
| Effect of gastrin on the in vivo incorporation of 14C-leucine into protein of the digestive tract | Q71262974 | ||
| Somatostatin | Q71288199 | ||
| Gut peptide receptor expression in human pancreatic cancers | Q40879057 | ||
| Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells | Q40887550 | ||
| Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2. | Q40893394 | ||
| Electron immunohistochemical evidence for the human intestinal I cell as the source of CCK | Q40899402 | ||
| Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV. | Q40909275 | ||
| Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells | Q40925307 | ||
| Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. | Q40926569 | ||
| Expression of progastrin-derived peptides and gastrin receptors in a panel of gastrointestinal carcinoma cell lines | Q40957887 | ||
| Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity | Q40979568 | ||
| Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats. | Q40987952 | ||
| Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits | Q41083601 | ||
| Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit | Q41090124 | ||
| Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. | Q41105921 | ||
| Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations | Q41110192 | ||
| The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract | Q41136904 | ||
| Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays. | Q41161065 | ||
| Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines. | Q41298572 | ||
| Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer | Q41362569 | ||
| Growth-promoting effects of glycine-extended progastrin | Q41454851 | ||
| Characterization of a bombesin/gastrin-releasing peptide receptor on a human gastric-cancer cell line | Q41462833 | ||
| Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160. | Q41468092 | ||
| Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors | Q41500760 | ||
| Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. | Q41503348 | ||
| Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2. | Q41525783 | ||
| Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin | Q41614766 | ||
| Molecular mechanisms for the control of translation by insulin | Q41644481 | ||
| The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades | Q41688659 | ||
| CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium | Q41694806 | ||
| Effects of a high-fat diet and L364,718 on growth of human pancreas cancer | Q41731843 | ||
| Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc-3 | Q41757507 | ||
| Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion | Q41827161 | ||
| Enhancing effect of partial gastrectomy on pancreatic carcinogenesis | Q42023653 | ||
| Neurotensin induces hyperplasia of the pancreas and growth of the gastric antrum in rats | Q42063322 | ||
| Enhancement by neurotensin of experimental carcinogenesis induced in rat colon by azoxymethane | Q42182438 | ||
| Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes | Q34020681 | ||
| Pancreatic cancer: does octreotide offer any promise? | Q34199362 | ||
| Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone | Q34216319 | ||
| G-protein-coupled receptors and signaling networks: emerging paradigms. | Q34296103 | ||
| Progastrin expression in mammalian pancreas | Q34410848 | ||
| Treatment of short-bowel syndrome | Q34436963 | ||
| G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy | Q34452090 | ||
| Chemotherapy and biotherapy in the treatment of neuroendocrine tumours | Q34474170 | ||
| Somatostatin and somatostatin analogues: diagnostic and therapeutic uses | Q34493829 | ||
| Biological actions and therapeutic potential of the glucagon-like peptides | Q34520645 | ||
| Fate of pancreatic nodules induced by raw soya flour in rats | Q34533168 | ||
| The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? | Q34698154 | ||
| Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides | Q34713867 | ||
| Effects of soybean flour on the pancreas of rats | Q35034641 | ||
| Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. | Q35199203 | ||
| Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer | Q35264411 | ||
| Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma | Q35350126 | ||
| Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence | Q35362209 | ||
| Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. | Q36245969 | ||
| Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility | Q36305282 | ||
| Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. | Q36438198 | ||
| Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa | Q37271046 | ||
| Processing and proliferative effects of human progastrin in transgenic mice | Q37360937 | ||
| Induction of intestinal epithelial proliferation by glucagon-like peptide 2. | Q37449481 | ||
| Cholecystokinin and gastrointestinal cancer | Q38031478 | ||
| Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide | Q38342425 | ||
| Expression of gastrin in developing gastric adenocarcinoma | Q38461739 | ||
| Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells | Q39328878 | ||
| Functional subdivision of islets of Langerhans and possible role of D cells | Q39356963 | ||
| The expression of progastrin, procholecystokinin and their hormonal products in pituitary cells | Q39580079 | ||
| Neurotensin stimulates growth of colon cancer | Q39617562 | ||
| A peptide resembling COOH-terminal tetrapeptide amide of gastrin from a new gastrointestinal endocrine cell type | Q39646369 | ||
| The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth | Q40548301 | ||
| Pathology of neuroblastic tumors. | Q40562033 | ||
| Gastrin-releasing peptide: a potential growth factor expressed in human neuroblastoma tumors(1). | Q40721923 | ||
| Gastrin-releasing peptide is a growth factor for human neuroblastomas. | Q40735271 | ||
| Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. | Q40742637 | ||
| GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF. | Q40793676 | ||
| Enterotrophic effects of glucagon-like peptide 2 are enhanced by neurotensin. | Q53832342 | ||
| Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptors. | Q53978716 | ||
| Clinical significance of gastrin receptors in human colon cancers. | Q54044246 | ||
| Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. | Q54149777 | ||
| Bombesin-induced pancreatic regeneration in pigs is mediated by p46Shc/p52Shc and p42/p44 mitogen-activated protein kinase upregulation. | Q54198873 | ||
| Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas | Q57756512 | ||
| Secretion of neurotensin from isolated perfused porcine ileum | Q58449359 | ||
| Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK | Q59066859 | ||
| Release and degradation of neurotensin during perfusion of rat small intestine with lipid | Q63608730 | ||
| Effect of Somatostatin on Normal and Gastric-Stimulated Cell Proliferation in the Gastric and Intestinal Mucosae of the Rat | Q66924500 | ||
| Neurotensin augments intestinal regeneration after small bowel resection in rats | Q67538438 | ||
| Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer | Q67541967 | ||
| Effect of neurotensin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas | Q67555296 | ||
| Role of gastrin and cholecystokinin in the growth-promoting action of bombesin on the gastroduodenal mucosa and the pancreas | Q67657011 | ||
| Aging and the Trophic Effects of Cholecystokinin, Bombesin and Pentagastrin on the Rat Pancreas | Q67698086 | ||
| Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet | Q67742802 | ||
| Interaction of neurotensin with caerulein or secretin on digestive tract growth in rats | Q67941723 | ||
| Neurotensin reduces microbial translocation and improves intestinal mucosa integrity after abdominal radiation | Q68120365 | ||
| Neurotensin stimulates growth of colonic mucosa in young and aged rats | Q68169705 | ||
| Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats | Q68182925 | ||
| Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro | Q68322039 | ||
| Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts | Q68325510 | ||
| The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia | Q68439110 | ||
| Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 | Q68581002 | ||
| Effects of cerulein on the normal pancreas and on experimental pancreatic carcinoma in the Syrian golden hamster | Q68992634 | ||
| Mechanisms of the trophic actions of bombesin on the pancreas | Q69028286 | ||
| Effect of neurotensin on pancreatic and gastric secretion and growth in rats | Q69031243 | ||
| Effect of chronically administered cholecystokinin on the nude mouse | Q69054681 | ||
| Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons | Q69356344 | ||
| The distribution of endocrine cells along the mouse small intestine. Bombesin and somatostatin producing cells | Q69378378 | ||
| Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines | Q69500065 | ||
| Effect of pentagastrin, secretin and cholecystokinin on growth and differentiation in organ cultured rabbit small intestine | Q69547404 | ||
| The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin | Q69580585 | ||
| Regulatory effects of gastrin and secretin on carcinomas of the stomach and colon | Q69581168 | ||
| Distribution of bombesin binding sites in the rat gastrointestinal tract | Q69837523 | ||
| Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo | Q69852351 | ||
| Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases | Q69855897 | ||
| Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line | Q69856242 | ||
| Effects of peptide YY on intestinal blood flow distribution and motility in the dog | Q69958137 | ||
| Neurotensin is produced by and secreted from classic small cell lung cancer cells | Q70081626 | ||
| Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations | Q70123394 | ||
| Effect of neurotensin on exocrine pancreatic secretion in dogs | Q70427130 | ||
| Somatostatin analogue inhibits intestinal regeneration | Q70621170 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocrinology | Q162606 |
| cell division | Q188909 | ||
| P304 | page(s) | 571-599 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues | |
| Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues | |||
| P478 | volume | 24 |
| Q38895540 | A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer |
| Q34452651 | Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene |
| Q82698059 | Cinnamtannin B-1, a natural antioxidant that reduces the effects of H(2)O(2) on CCK-8-evoked responses in mouse pancreatic acinar cells |
| Q36116233 | Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers |
| Q36376528 | Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas |
| Q24654005 | Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells |
| Q42575718 | Dependence of Relative Expression of NTR1 and EGFR on Cell Density and Extracellular pH in Human Pancreatic Cancer Cell Lines |
| Q24808665 | Dietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis |
| Q33849781 | Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? |
| Q42971877 | Effect of cinnamtannin B-1 on cholecystokinin-8-evoked responses in mouse pancreatic acinar cells |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q39721404 | Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease. |
| Q37350024 | Gastrin, cholecystokinin and gastrointestinal tract functions in mammals |
| Q47719905 | Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis |
| Q38504442 | Gene expression in response to ionizing radiation and family history of gastric cancer |
| Q37403983 | Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). |
| Q36629054 | How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. |
| Q37183462 | Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth. |
| Q35923382 | Hypergastrinemia |
| Q81557286 | Hypergastrinemia--diagnosis and treatment |
| Q88864973 | Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs |
| Q51825106 | Increased mortality in prostate carcinoma and smoking-related disease after parietal cell vagotomy: a long-term follow-up study. |
| Q95820838 | Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma |
| Q51813912 | Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog. |
| Q40517012 | Inhibition of mitochondrial gene transcription suppresses neurotensin secretion in the human carcinoid cell line BON. |
| Q41719911 | Intestinal gene expression profiles of piglets benefit from maternal supplementation with a yeast mannan-rich fraction during gestation and lactation |
| Q87177179 | Melatonin modulates Ca2+ mobilization and amylase release in response to cholecystokinin octapeptide in mouse pancreatic acinar cells |
| Q40476398 | Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. |
| Q64917588 | Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality? |
| Q34483541 | Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib |
| Q36540348 | Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy |
| Q36449538 | Neurotensin and its receptors in the control of glucose homeostasis |
| Q35060343 | Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells |
| Q46813475 | Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas |
| Q39336194 | Neurotensin receptors in pancreatic ductal carcinomas |
| Q41130088 | Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells |
| Q57739115 | Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives |
| Q37068055 | PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion |
| Q38185618 | Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy |
| Q87487176 | Pharmacological dose of melatonin reduces cytosolic calcium load in response to cholecystokinin in mouse pancreatic acinar cells |
| Q39799396 | Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells |
| Q61783507 | Prognostic significance of gastrin expression in patients undergoing R0 gastrectomy for adenocarcinoma |
| Q36474945 | Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines |
| Q35130509 | Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer |
| Q36038476 | Role of gastrointestinal hormones in neuroblastoma |
| Q34100964 | Suppression of Neurotensin Receptor Type 1 Expression and Function by Histone Deacetylase Inhibitors in Human Colorectal Cancers |
| Q38216009 | Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives |
| Q52579668 | Targeting the gut microbiome to treat the osteoarthritis of obesity. |
| Q40212349 | The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells |
| Q37120486 | The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2. |
| Q38920728 | The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells |
| Q40559835 | The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase. |
| Q35895961 | The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer |
| Q38472348 | The use of peptide analogs for the treatment of gastrointestinal, pancreatic, liver and urinary bladder cancers |
Search more.